Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Tigermed Australia
Scientific Title
A Phase I/II, Open-Label, Multicenter Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of GB261 in Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia